Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID).

Witt, M; Grunke, M; Proft, F; Baeuerle, M; Aringer, M; Burmester, G; Chehab, G; Fiehn, C; Fischer-Betz, R; Fleck, M; Freivogel, K; Haubitz, M; Kötter, I; Lovric, S; Metzler, C; Rubberth-Roth, A; Schwarting, A; Specker, C; Tony, H-P; Unger, L; Wassenberg, S; Dörner, T; Schulze-Koops, H

Witt, M; Grunke, M; Proft, F; Baeuerle, M; Aringer, M; Burmester, G; Chehab, G; Fiehn, C; Fischer-Betz, R; Fleck, M; Freivogel, K; Haubitz, M; Kötter, I; Lovric, S; Metzler, C; Rubberth-Roth, A; Schwarting, A; Specker, C; Tony, H-P; Unger, L; Wassenberg, S; Dörner, T; Schulze-Koops, H.

Afiliação

Witt M; 1Division of Rheumatology, Medizinische Klinik und Poliklinik IV, University Hospital Munich, Germany.

Lupus ; 22(11): 1142-9, 2013 Oct.

Article em En | MEDLINE | ID: mdl-24057058

Assuntos

Anticorpos Monoclonais Murinos/uso terapêutico; Lúpus Eritematoso Sistêmico/tratamento farmacológico; Adulto; Anticorpos Monoclonais Murinos/efeitos adversos; Estudos de Coortes; Feminino; Humanos; Masculino; Uso Off-Label; Estudos Retrospectivos; Rituximab

Palavras-chave

B lymphocytes; Systemic lupus erythematosus; cohort studies; efficacy; rituximab; safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Murinos / Lúpus Eritematoso Sistêmico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google